A Revisit to the Pretargeting Concept-A Target Conversion.

Area of Science:

• Oncology
• Radiopharmaceutical Therapy
• Molecular Imaging

Background:

• Pretargeting strategies enhance tumor targeting compared to direct radiolabeled antibody methods.
• Despite fewer investigations due to multiple injections, pretargeting shows therapeutic promise via high tumor-to-non-tumor (T/NT) ratios.

Purpose of the Study:

• To provide a quantitative understanding of the pretargeting concept.
• To accelerate the clinical development and translation of pretargeting strategies.
• To assist researchers new to pretargeting in its application.

Main Methods:

• Review of existing literature on pretargeting strategies.
• Focus on the quantitative aspects and principles of pretargeting.
• Presentation of concepts with basic calculus and chemistry knowledge.

Main Results:

• Pretargeting achieves significantly higher T/NT ratios than direct targeting.
• Quantitative understanding is crucial for optimizing pretargeting efficacy.
• The review aims to demystify pretargeting for broader research adoption.

Conclusions:

• Pretargeting is a powerful tool for cancer therapy due to its high specificity.
• A clear quantitative framework can facilitate pretargeting's translation to clinical practice.
• This review serves as a foundational guide for researchers entering the pretargeting field.